COVID-19Patents Assuring Social Justice for Access to COVID-19 Vaccines: Part II Fixing the Broken Supply Chain Through InformationOctober 21, 2020 This is Part II of a two-part article examining the changes that we need in…Doris Estelle Long COVID-19Patents Assuring Social Justice for Access to COVID-19 Vaccines: Part 1 Fixing the Broken Disclosure SystemOctober 5, 2020 This is Part 1 of a two-part article examining the changes that we need in…Doris Estelle Long PatentsTRIPS Patents and Trade: Opportunities and Challenges in the Global Healthcare Market September 11, 2020 The present global COVID-19 pandemic has highlighted in stark terms some of the fault lines…Doris Estelle Long Patent PoolsPatents The Role of the Medicines Patent Pool (MPP) in the Context of the Global Access to Medicines MovementAugust 10, 2020 The Medicines Patent Pool (MPP) has played a key role in the access to medicines…Sakshi Chandna Patent PoolsPatentsTRIPSVoluntary Licenses Patent Pools: An Attempt to Reinforce the Status Quo and Private OrderingJuly 20, 2020 The experience of the HIV/AIDS epidemic wherein patents hindered access to affordable medicines raises serious…Shirin Syed Data ExclusivitiesPatents Is it Time to Do Away with Data Exclusivity?July 8, 2020 If there is a lesson from COVID-19, it is the need to look at the…Srividhya RagavanJonathan Kimball PatentsTRIPS IP barriers in tackling COVID 19: Anything in TRIPS to help out?July 1, 2020 The recent World Health Organization Assembly (WHA) resolution calls for timely and equitable access to…Shirin Syed Data ExclusivitiesPatents Drug Exclusivities in the US: Is it Justified? (Part 2 of 2)June 25, 2020 This is Part 2 of a two-part Article. In Part I, I dealt with Henry…Bhavik Shukla Data ExclusivitiesPatents Drug Exclusivities in the US: Is it justified? (Part 1 of 2)June 25, 2020 This is Part 1 of a two-part Article. Data and market exclusivities, often termed as…Bhavik Shukla COVID-19ExhaustionPatentsTRIPS TRIPS, COVID-19 and the Right to Repair and Produce Needed Medical Products in Emergencies (Part 2 of 2)June 11, 2020 This is Part 2 of a two-part article. In response to the COVID-19 pandemic, companies,…Joshua D. Sarnoff 1 2 Next Latest Posts Search Search Blog Front Page BLOG POSTS Re-Calibrating COVID Diplomacy 2021: A Changed IP Landscape for Defeating COVID-19 The Under-Appreciated Virtue of Transparency in Combatting COVID-19 The India South Africa Proposal: Strengths & Weaknesses Assuring Social Justice for Access to COVID-19 Vaccines: Part II Fixing the Broken Supply Chain Through Information CATEGORIES COVID-19 15 Data Exclusivities 4 Deceptive Claims 1 Exhaustion 2 Experimental Use 1 IPAB 1 Patent Pools 2 Patents 15 Right to Health 1 TAMU 1 Trade Policy 1 TRIPS 15 TRIPS Flexibilities 2 Vaccines 2 Voluntary Licenses 1
COVID-19Patents Assuring Social Justice for Access to COVID-19 Vaccines: Part 1 Fixing the Broken Disclosure SystemOctober 5, 2020 This is Part 1 of a two-part article examining the changes that we need in…Doris Estelle Long PatentsTRIPS Patents and Trade: Opportunities and Challenges in the Global Healthcare Market September 11, 2020 The present global COVID-19 pandemic has highlighted in stark terms some of the fault lines…Doris Estelle Long Patent PoolsPatents The Role of the Medicines Patent Pool (MPP) in the Context of the Global Access to Medicines MovementAugust 10, 2020 The Medicines Patent Pool (MPP) has played a key role in the access to medicines…Sakshi Chandna Patent PoolsPatentsTRIPSVoluntary Licenses Patent Pools: An Attempt to Reinforce the Status Quo and Private OrderingJuly 20, 2020 The experience of the HIV/AIDS epidemic wherein patents hindered access to affordable medicines raises serious…Shirin Syed Data ExclusivitiesPatents Is it Time to Do Away with Data Exclusivity?July 8, 2020 If there is a lesson from COVID-19, it is the need to look at the…Srividhya RagavanJonathan Kimball PatentsTRIPS IP barriers in tackling COVID 19: Anything in TRIPS to help out?July 1, 2020 The recent World Health Organization Assembly (WHA) resolution calls for timely and equitable access to…Shirin Syed Data ExclusivitiesPatents Drug Exclusivities in the US: Is it Justified? (Part 2 of 2)June 25, 2020 This is Part 2 of a two-part Article. In Part I, I dealt with Henry…Bhavik Shukla Data ExclusivitiesPatents Drug Exclusivities in the US: Is it justified? (Part 1 of 2)June 25, 2020 This is Part 1 of a two-part Article. Data and market exclusivities, often termed as…Bhavik Shukla COVID-19ExhaustionPatentsTRIPS TRIPS, COVID-19 and the Right to Repair and Produce Needed Medical Products in Emergencies (Part 2 of 2)June 11, 2020 This is Part 2 of a two-part article. In response to the COVID-19 pandemic, companies,…Joshua D. Sarnoff 1 2 Next Latest Posts Search Search Blog Front Page BLOG POSTS Re-Calibrating COVID Diplomacy 2021: A Changed IP Landscape for Defeating COVID-19 The Under-Appreciated Virtue of Transparency in Combatting COVID-19 The India South Africa Proposal: Strengths & Weaknesses Assuring Social Justice for Access to COVID-19 Vaccines: Part II Fixing the Broken Supply Chain Through Information CATEGORIES COVID-19 15 Data Exclusivities 4 Deceptive Claims 1 Exhaustion 2 Experimental Use 1 IPAB 1 Patent Pools 2 Patents 15 Right to Health 1 TAMU 1 Trade Policy 1 TRIPS 15 TRIPS Flexibilities 2 Vaccines 2 Voluntary Licenses 1
PatentsTRIPS Patents and Trade: Opportunities and Challenges in the Global Healthcare Market September 11, 2020 The present global COVID-19 pandemic has highlighted in stark terms some of the fault lines…Doris Estelle Long Patent PoolsPatents The Role of the Medicines Patent Pool (MPP) in the Context of the Global Access to Medicines MovementAugust 10, 2020 The Medicines Patent Pool (MPP) has played a key role in the access to medicines…Sakshi Chandna Patent PoolsPatentsTRIPSVoluntary Licenses Patent Pools: An Attempt to Reinforce the Status Quo and Private OrderingJuly 20, 2020 The experience of the HIV/AIDS epidemic wherein patents hindered access to affordable medicines raises serious…Shirin Syed Data ExclusivitiesPatents Is it Time to Do Away with Data Exclusivity?July 8, 2020 If there is a lesson from COVID-19, it is the need to look at the…Srividhya RagavanJonathan Kimball PatentsTRIPS IP barriers in tackling COVID 19: Anything in TRIPS to help out?July 1, 2020 The recent World Health Organization Assembly (WHA) resolution calls for timely and equitable access to…Shirin Syed Data ExclusivitiesPatents Drug Exclusivities in the US: Is it Justified? (Part 2 of 2)June 25, 2020 This is Part 2 of a two-part Article. In Part I, I dealt with Henry…Bhavik Shukla Data ExclusivitiesPatents Drug Exclusivities in the US: Is it justified? (Part 1 of 2)June 25, 2020 This is Part 1 of a two-part Article. Data and market exclusivities, often termed as…Bhavik Shukla COVID-19ExhaustionPatentsTRIPS TRIPS, COVID-19 and the Right to Repair and Produce Needed Medical Products in Emergencies (Part 2 of 2)June 11, 2020 This is Part 2 of a two-part article. In response to the COVID-19 pandemic, companies,…Joshua D. Sarnoff 1 2 Next Latest Posts Search Search Blog Front Page BLOG POSTS Re-Calibrating COVID Diplomacy 2021: A Changed IP Landscape for Defeating COVID-19 The Under-Appreciated Virtue of Transparency in Combatting COVID-19 The India South Africa Proposal: Strengths & Weaknesses Assuring Social Justice for Access to COVID-19 Vaccines: Part II Fixing the Broken Supply Chain Through Information CATEGORIES COVID-19 15 Data Exclusivities 4 Deceptive Claims 1 Exhaustion 2 Experimental Use 1 IPAB 1 Patent Pools 2 Patents 15 Right to Health 1 TAMU 1 Trade Policy 1 TRIPS 15 TRIPS Flexibilities 2 Vaccines 2 Voluntary Licenses 1
Patent PoolsPatents The Role of the Medicines Patent Pool (MPP) in the Context of the Global Access to Medicines MovementAugust 10, 2020 The Medicines Patent Pool (MPP) has played a key role in the access to medicines…Sakshi Chandna Patent PoolsPatentsTRIPSVoluntary Licenses Patent Pools: An Attempt to Reinforce the Status Quo and Private OrderingJuly 20, 2020 The experience of the HIV/AIDS epidemic wherein patents hindered access to affordable medicines raises serious…Shirin Syed Data ExclusivitiesPatents Is it Time to Do Away with Data Exclusivity?July 8, 2020 If there is a lesson from COVID-19, it is the need to look at the…Srividhya RagavanJonathan Kimball PatentsTRIPS IP barriers in tackling COVID 19: Anything in TRIPS to help out?July 1, 2020 The recent World Health Organization Assembly (WHA) resolution calls for timely and equitable access to…Shirin Syed Data ExclusivitiesPatents Drug Exclusivities in the US: Is it Justified? (Part 2 of 2)June 25, 2020 This is Part 2 of a two-part Article. In Part I, I dealt with Henry…Bhavik Shukla Data ExclusivitiesPatents Drug Exclusivities in the US: Is it justified? (Part 1 of 2)June 25, 2020 This is Part 1 of a two-part Article. Data and market exclusivities, often termed as…Bhavik Shukla COVID-19ExhaustionPatentsTRIPS TRIPS, COVID-19 and the Right to Repair and Produce Needed Medical Products in Emergencies (Part 2 of 2)June 11, 2020 This is Part 2 of a two-part article. In response to the COVID-19 pandemic, companies,…Joshua D. Sarnoff 1 2 Next Latest Posts Search Search Blog Front Page BLOG POSTS Re-Calibrating COVID Diplomacy 2021: A Changed IP Landscape for Defeating COVID-19 The Under-Appreciated Virtue of Transparency in Combatting COVID-19 The India South Africa Proposal: Strengths & Weaknesses Assuring Social Justice for Access to COVID-19 Vaccines: Part II Fixing the Broken Supply Chain Through Information CATEGORIES COVID-19 15 Data Exclusivities 4 Deceptive Claims 1 Exhaustion 2 Experimental Use 1 IPAB 1 Patent Pools 2 Patents 15 Right to Health 1 TAMU 1 Trade Policy 1 TRIPS 15 TRIPS Flexibilities 2 Vaccines 2 Voluntary Licenses 1
Patent PoolsPatentsTRIPSVoluntary Licenses Patent Pools: An Attempt to Reinforce the Status Quo and Private OrderingJuly 20, 2020 The experience of the HIV/AIDS epidemic wherein patents hindered access to affordable medicines raises serious…Shirin Syed Data ExclusivitiesPatents Is it Time to Do Away with Data Exclusivity?July 8, 2020 If there is a lesson from COVID-19, it is the need to look at the…Srividhya RagavanJonathan Kimball PatentsTRIPS IP barriers in tackling COVID 19: Anything in TRIPS to help out?July 1, 2020 The recent World Health Organization Assembly (WHA) resolution calls for timely and equitable access to…Shirin Syed Data ExclusivitiesPatents Drug Exclusivities in the US: Is it Justified? (Part 2 of 2)June 25, 2020 This is Part 2 of a two-part Article. In Part I, I dealt with Henry…Bhavik Shukla Data ExclusivitiesPatents Drug Exclusivities in the US: Is it justified? (Part 1 of 2)June 25, 2020 This is Part 1 of a two-part Article. Data and market exclusivities, often termed as…Bhavik Shukla COVID-19ExhaustionPatentsTRIPS TRIPS, COVID-19 and the Right to Repair and Produce Needed Medical Products in Emergencies (Part 2 of 2)June 11, 2020 This is Part 2 of a two-part article. In response to the COVID-19 pandemic, companies,…Joshua D. Sarnoff 1 2 Next Latest Posts Search Search Blog Front Page BLOG POSTS Re-Calibrating COVID Diplomacy 2021: A Changed IP Landscape for Defeating COVID-19 The Under-Appreciated Virtue of Transparency in Combatting COVID-19 The India South Africa Proposal: Strengths & Weaknesses Assuring Social Justice for Access to COVID-19 Vaccines: Part II Fixing the Broken Supply Chain Through Information CATEGORIES COVID-19 15 Data Exclusivities 4 Deceptive Claims 1 Exhaustion 2 Experimental Use 1 IPAB 1 Patent Pools 2 Patents 15 Right to Health 1 TAMU 1 Trade Policy 1 TRIPS 15 TRIPS Flexibilities 2 Vaccines 2 Voluntary Licenses 1
Data ExclusivitiesPatents Is it Time to Do Away with Data Exclusivity?July 8, 2020 If there is a lesson from COVID-19, it is the need to look at the…Srividhya RagavanJonathan Kimball PatentsTRIPS IP barriers in tackling COVID 19: Anything in TRIPS to help out?July 1, 2020 The recent World Health Organization Assembly (WHA) resolution calls for timely and equitable access to…Shirin Syed Data ExclusivitiesPatents Drug Exclusivities in the US: Is it Justified? (Part 2 of 2)June 25, 2020 This is Part 2 of a two-part Article. In Part I, I dealt with Henry…Bhavik Shukla Data ExclusivitiesPatents Drug Exclusivities in the US: Is it justified? (Part 1 of 2)June 25, 2020 This is Part 1 of a two-part Article. Data and market exclusivities, often termed as…Bhavik Shukla COVID-19ExhaustionPatentsTRIPS TRIPS, COVID-19 and the Right to Repair and Produce Needed Medical Products in Emergencies (Part 2 of 2)June 11, 2020 This is Part 2 of a two-part article. In response to the COVID-19 pandemic, companies,…Joshua D. Sarnoff 1 2 Next Latest Posts Search Search Blog Front Page BLOG POSTS Re-Calibrating COVID Diplomacy 2021: A Changed IP Landscape for Defeating COVID-19 The Under-Appreciated Virtue of Transparency in Combatting COVID-19 The India South Africa Proposal: Strengths & Weaknesses Assuring Social Justice for Access to COVID-19 Vaccines: Part II Fixing the Broken Supply Chain Through Information CATEGORIES COVID-19 15 Data Exclusivities 4 Deceptive Claims 1 Exhaustion 2 Experimental Use 1 IPAB 1 Patent Pools 2 Patents 15 Right to Health 1 TAMU 1 Trade Policy 1 TRIPS 15 TRIPS Flexibilities 2 Vaccines 2 Voluntary Licenses 1
PatentsTRIPS IP barriers in tackling COVID 19: Anything in TRIPS to help out?July 1, 2020 The recent World Health Organization Assembly (WHA) resolution calls for timely and equitable access to…Shirin Syed Data ExclusivitiesPatents Drug Exclusivities in the US: Is it Justified? (Part 2 of 2)June 25, 2020 This is Part 2 of a two-part Article. In Part I, I dealt with Henry…Bhavik Shukla Data ExclusivitiesPatents Drug Exclusivities in the US: Is it justified? (Part 1 of 2)June 25, 2020 This is Part 1 of a two-part Article. Data and market exclusivities, often termed as…Bhavik Shukla COVID-19ExhaustionPatentsTRIPS TRIPS, COVID-19 and the Right to Repair and Produce Needed Medical Products in Emergencies (Part 2 of 2)June 11, 2020 This is Part 2 of a two-part article. In response to the COVID-19 pandemic, companies,…Joshua D. Sarnoff 1 2 Next Latest Posts Search Search Blog Front Page BLOG POSTS Re-Calibrating COVID Diplomacy 2021: A Changed IP Landscape for Defeating COVID-19 The Under-Appreciated Virtue of Transparency in Combatting COVID-19 The India South Africa Proposal: Strengths & Weaknesses Assuring Social Justice for Access to COVID-19 Vaccines: Part II Fixing the Broken Supply Chain Through Information CATEGORIES COVID-19 15 Data Exclusivities 4 Deceptive Claims 1 Exhaustion 2 Experimental Use 1 IPAB 1 Patent Pools 2 Patents 15 Right to Health 1 TAMU 1 Trade Policy 1 TRIPS 15 TRIPS Flexibilities 2 Vaccines 2 Voluntary Licenses 1
Data ExclusivitiesPatents Drug Exclusivities in the US: Is it Justified? (Part 2 of 2)June 25, 2020 This is Part 2 of a two-part Article. In Part I, I dealt with Henry…Bhavik Shukla Data ExclusivitiesPatents Drug Exclusivities in the US: Is it justified? (Part 1 of 2)June 25, 2020 This is Part 1 of a two-part Article. Data and market exclusivities, often termed as…Bhavik Shukla COVID-19ExhaustionPatentsTRIPS TRIPS, COVID-19 and the Right to Repair and Produce Needed Medical Products in Emergencies (Part 2 of 2)June 11, 2020 This is Part 2 of a two-part article. In response to the COVID-19 pandemic, companies,…Joshua D. Sarnoff 1 2 Next Latest Posts Search Search Blog Front Page BLOG POSTS Re-Calibrating COVID Diplomacy 2021: A Changed IP Landscape for Defeating COVID-19 The Under-Appreciated Virtue of Transparency in Combatting COVID-19 The India South Africa Proposal: Strengths & Weaknesses Assuring Social Justice for Access to COVID-19 Vaccines: Part II Fixing the Broken Supply Chain Through Information CATEGORIES COVID-19 15 Data Exclusivities 4 Deceptive Claims 1 Exhaustion 2 Experimental Use 1 IPAB 1 Patent Pools 2 Patents 15 Right to Health 1 TAMU 1 Trade Policy 1 TRIPS 15 TRIPS Flexibilities 2 Vaccines 2 Voluntary Licenses 1
Data ExclusivitiesPatents Drug Exclusivities in the US: Is it justified? (Part 1 of 2)June 25, 2020 This is Part 1 of a two-part Article. Data and market exclusivities, often termed as…Bhavik Shukla COVID-19ExhaustionPatentsTRIPS TRIPS, COVID-19 and the Right to Repair and Produce Needed Medical Products in Emergencies (Part 2 of 2)June 11, 2020 This is Part 2 of a two-part article. In response to the COVID-19 pandemic, companies,…Joshua D. Sarnoff 1 2 Next Latest Posts Search Search Blog Front Page BLOG POSTS Re-Calibrating COVID Diplomacy 2021: A Changed IP Landscape for Defeating COVID-19 The Under-Appreciated Virtue of Transparency in Combatting COVID-19 The India South Africa Proposal: Strengths & Weaknesses Assuring Social Justice for Access to COVID-19 Vaccines: Part II Fixing the Broken Supply Chain Through Information CATEGORIES COVID-19 15 Data Exclusivities 4 Deceptive Claims 1 Exhaustion 2 Experimental Use 1 IPAB 1 Patent Pools 2 Patents 15 Right to Health 1 TAMU 1 Trade Policy 1 TRIPS 15 TRIPS Flexibilities 2 Vaccines 2 Voluntary Licenses 1
COVID-19ExhaustionPatentsTRIPS TRIPS, COVID-19 and the Right to Repair and Produce Needed Medical Products in Emergencies (Part 2 of 2)June 11, 2020 This is Part 2 of a two-part article. In response to the COVID-19 pandemic, companies,…Joshua D. Sarnoff 1 2 Next